Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Extension Study of MBA-P01 (Newlux) for Glabellar Lines
NCT05321979Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Feb 2022
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluorometholone acetate in glabellar lines, sponsored by Medytox Inc.. Started Feb 2022; status: completed.
02
Drugs
fluorometholone acetate
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT05321979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05321979.